Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SNSS

Sunesis Pharmaceuticals (SNSS)

Sunesis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNSS
DateTimeSourceHeadlineSymbolCompany
11/14/20114:03PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
11/14/20117:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Third Quarter 2011 Financial ResultsNASDAQ:SNSSSunesis Pharmaceuticals Inc
11/08/20117:00AMGlobeNewswire Inc.Sunesis to Present at the Lazard Capital Markets 8th Annual Healthcare ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/19/20115:02PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
10/19/20114:15PMGlobeNewswire Inc.Sunesis Secures $25 Million Tranched Loan FacilityNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/18/201110:34AMGlobeNewswire Inc.Sunesis Pharmaceuticals, Inc. (SNSS) CEO to Ring The NASDAQ Stock Market Closing BellNASDAQ:SNSSSunesis Pharmaceuticals Inc
10/11/20117:00AMGlobeNewswire Inc.Sunesis to Host Analyst & Institutional Investor Meeting on October 19, 2011NASDAQ:SNSSSunesis Pharmaceuticals Inc
09/26/20117:00AMGlobeNewswire Inc.Sunesis Announces Initiation of Phase 1 Study of MLN2480 in Advanced Solid TumorsNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/13/20117:30AMGlobeNewswire Inc.Sunesis to Present at the UBS Global Life Sciences ConferenceNASDAQ:SNSSSunesis Pharmaceuticals Inc
09/01/20117:00AMGlobeNewswire Inc.Sunesis to Present at Upcoming Investor ConferencesNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/11/20114:56PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/11/20114:50PMEdgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/11/20114:03PMEdgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:SNSSSunesis Pharmaceuticals Inc
08/11/20117:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Reports Second Quarter 2011 Financial ResultsNASDAQ:SNSSSunesis Pharmaceuticals Inc
08/03/20117:00AMGlobeNewswire Inc.Sunesis Pharmaceuticals Issued Important U.S. Patent Covering Vosaroxin Use to Treat LeukemiaNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/20/20117:30AMGlobeNewswire Inc.Sunesis Announces Publication of Phase 1b Data of Vosaroxin in Relapsed or Refractory Acute LeukemiaNASDAQ:SNSSSunesis Pharmaceuticals Inc
07/18/20116:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/12/20113:50PMEdgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
07/05/20116:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/30/20115:14PMEdgar (US Regulatory)Amended Quarterly Report (10-Q/A)NASDAQ:SNSSSunesis Pharmaceuticals Inc
06/06/20114:45PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:SNSSSunesis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:SNSS